Concerto Biosciences
United States
activeseries-a
series-a
Stage
2020
Founded
1
Investors
About
Concerto Biosciences develops microbial 'ensembles' as therapeutic and consumer products by leveraging its kChip technology to map and predict microbial interactions, focusing initially on skin health applications like eczema treatment.
Explore Concerto Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.